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Single-breath-hold photoacoustic computed
tomography of the breast
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Ruiying Zhang2 & Lihong V. Wang1,4
We have developed a single-breath-hold photoacoustic computed tomography (SBH-PACT)
system to reveal detailed angiographic structures in human breasts. SBH-PACT features a
deep penetration depth (4 cm in vivo) with high spatial and temporal resolutions (255 µm in-
plane resolution and a 10 Hz 2D frame rate). By scanning the entire breast within a single
breath hold (~15 s), a volumetric image can be acquired and subsequently reconstructed
utilizing 3D back-projection with negligible breathing-induced motion artifacts. SBH-PACT
clearly reveals tumors by observing higher blood vessel densities associated with tumors at
high spatial resolution, showing early promise for high sensitivity in radiographically dense
breasts. In addition to blood vessel imaging, the high imaging speed enables dynamic studies,
such as photoacoustic elastography, which identiﬁes tumors by showing less compliance. We
imaged breast cancer patients with breast sizes ranging from B cup to DD cup, and skin
pigmentations ranging from light to dark. SBH-PACT identiﬁed all the tumors without
resorting to ionizing radiation or exogenous contrast, posing no health risks.
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Breast cancer is the second most common cancer to affectwomen in the U.S. and is the second ranked causeof cancer-related deaths. About 1 in 8 (12%) women in the
U.S. will develop invasive breast cancer during their lifetime1.
Multiple large prospective clinical trials have demonstrated the
importance of early detection in improving breast cancer survi-
val2–4. While mammography is currently the gold standard used
for breast cancer screening, it utilizes ionizing radiation and
has lower sensitivity in women with dense breasts5, 6. Ultra-
sonography has been used as an adjunct to mammography, but
suffers from speckle artifacts and low speciﬁcity7, 8. Magnetic
resonance imaging (MRI) poses a large ﬁnancial burden and
requires the use of intravenous contrast agents that can cause
allergy9, kidney damage10, and permanent deposition in the
central nervous system11. Diffuse optical tomography has been
investigated to provide functional optical contrast. However, the
spatial resolution of the current prototypes limits their clinical
use12, 13. Overall, each modality has notable advantages and
limitations. Photoacoustic computed tomography (PACT) is
a promising complementary modality that overcomes many of
these limitations.
PACT—ultrasonically imaging optical contrast via the photo-
acoustic effect—breaks through the ~1mm optical diffusion
limit on penetration for high-resolution optical imaging in deep
tissues14, 15. It combines the functional optical contrast of diffuse
optical tomography and the high spatial resolution of ultra-
sonography. The rich contrast bestowed by optical absorption,
which is related to various intrinsic and extrinsic contrast origins,
enables PACT to perform structural, functional, and molecular
imaging16. When a short-pulsed laser irradiates biological tissues,
wideband ultrasonic waves (referred to as photoacoustic waves)
are induced by transient thermoelastic expansion. The photo-
acoustic (PA) waves are then simultaneously measured by
ultrasonic transducers around the tissue and are used to recon-
struct the optical absorption distribution in the tissue17. In the
near-infrared (NIR) region, the 1/e attenuation coefﬁcient
(1.0–1.3 cm−1)18 for light in an average breast is less than twice
that for mammographic X-rays (0.5–0.8 cm−1)19. However, the
optical absorption contrast of soft tissue is much higher than
X-ray contrast20. For breast imaging, PACT can exploit these
advantages to the fullest, offering high spatial and temporal
resolutions with sufﬁciently deep nonionizing optical
penetration21, 22. As the principal optical absorber in the NIR
region, hemoglobin provides an endogenous contrast for imaging
of blood vessels. A high density of blood vessels should correlate
with angiogenesis23–25, which plays an important role in tumor
growth and metastasis26.
Several breast PACT systems have been developed, employing
different light illumination and detection schemes27–36. These
systems have advanced PACT toward clinical application, but
ongoing limitations remain to be addressed. Here, we consider
ﬁve main factors: (1) sufﬁcient penetration depth to accom-
modate most breast sizes and skin colors, (2) high spatial reso-
lution to reveal detailed angiographic structures, (3) high
temporal resolution to minimize motion artifacts and enable
dynamic or functional studies, (4) minimal limited-view artifacts,
and (5) sufﬁcient noise-equivalent sensitivity and contrast-to-
noise ratio to detect breast masses.
Speciﬁcally, the current systems’ limitations mainly arise from
their long scanning times27–29 and/or limited-view apertures
(i.e., missing data or a <2π steradian solid angle)29–35. Toi et al.
recently reported a photoacoustic imaging system with a hemi-
spherical detector array27, which was modiﬁed from a previous
design28. Although the design for acoustic detection is slightly
different, both used a sparse hemispherical detector array and
scanned in a spiral pattern on a plane. The dense sampling, and
the nearly isotropic 3D spatial resolutions produced elegant
vascular images, but tumor detection was limited by respiratory
motion artifacts resulting from the long scanning time (~4 min).
Although co-registration partially mitigated the breathing motion
distortion, the non-rigidity of the breast compromised the
effectiveness. While larger vessels were coregistered, small tumor
vessels, which often occur in small clusters, could be challenging
to be imaged with partial data and even more difﬁcult to be
coregistered. Other groups have used planar transducer arrays30–
33 and arc-shaped arrays34 for breast imaging. However, the
limited views of these systems decreased their overall
performances37, 38. Consequently, most blood vessels were not
well visualized in their images. The same problem occurred with
linear transducer arrays, either ﬁxed in position35 or scanned29. A
ring-shaped array of 32 elements was developed at presumably
relatively low system cost36. However, the low number of ele-
ments severely limited the ﬁeld of view due to the spatial Nyquist
sampling criterion, resulting in degradation of image quality39.
Here, we report a signiﬁcant advancement in breast PACT
technology that overcomes all of the aforementioned limitations.
Our breast imaging modality—single-breath-hold PACT (SBH-
PACT)—is the ﬁrst PACT system that meets the aforementioned
ﬁve conditions: (1, 2) Combining 1064-nm light illumination and
a 2.25-MHz unfocused ultrasonic transducer array, SBH-PACT
achieved up to 4 cm in vivo imaging depth and a 255 µm in-plane
resolution (approximately four times ﬁner than that of contrast-
enhanced MRI40). (3) Equipped with one-to-one mapped signal
ampliﬁcation and data acquisition (DAQ) circuits, SBH-PACT
can obtain an entire 2D cross-sectional breast image with a single
laser pulse, or obtain a volumetric 3D image of the entire breast
by fast elevational scanning within a single breath-hold (~15 s).
The 10 Hz 2D frame rate, currently limited by the laser repetition
rate, enables SBH-PACT to observe biological dynamics in a
cross-section associated with respiration and heartbeats without
motion artifacts. (4) A full-ring 512-element ultrasonic transdu-
cer array enables SBH-PACT for full-view ﬁdelity in 2D imaging
planes and delivers high image quality. (5) Capitalizing on the
optimized illumination method and signal ampliﬁcation, SBH-
PACT achieves sufﬁcient noise-equivalent sensitivity to clearly
reveal detailed angiographic structures both inside and outside
breast tumors without the use of exogenous contrast agents.
In this pilot study, SBH-PACT was used to image one healthy
volunteer and seven breast cancer patients. SBH-PACT clearly
identiﬁed eight of the nine breast tumors by delineation of
angiographic anatomy. These tumors were subsequently veriﬁed
by ultrasound-guided biopsy. In addition, to improve on the
interpretation of images, we developed an algorithm to highlight
tumors automatically. Tumors were clearly revealed by SBH-
PACT in all breasts even in radiographically dense breasts, which
could not be readily imaged by mammography. Taking advantage
of the high imaging speed, we demonstrated elastographic SBH-
PACT for tumor detection by assessing deformations caused by
breathing. SBH-PACT elastography identiﬁed the tumor missed in
angiographic imaging, and thus improved the sensitivity of tumor
detection. At such high spatiotemporal resolutions, SBH-PACT is
able to differentiate arteries from veins by detecting blood ﬂow-
mediated arterial deformation at the heartbeat frequency.
Results
SBH-PACT of healthy breast anatomy and dynamics. The SBH-
PACT system is placed underneath a patient bed with minimal
separation from the top surface of the bed to the top scanning
position of the ultrasonic transducer array (Fig. 1a and Supple-
mentary Fig. 1). With the patient lying prone on the bed, the
breast to be imaged is slightly compressed against the chest wall
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by a soft agar pillow. Compared to craniocaudal or mediolateral
breast compression, compression against the chest wall not only
avoids pain, but also gives the least thickness breast tissue for light
to penetrate from the nipple to the chest wall. The laser illumi-
nates the breast from beneath the patient’s breast, and the
ultrasonic transducer array detects photoacoustic waves cir-
cumferentially around the breast. The light beam is converted
into a donut shape via an axicon lens followed by an engineered
diffuser. Compared to a Gaussian beam, the donut beam provides
more uniform illumination inside the breast (Supplementary
Fig. 2) and also deposits less energy on the nipple and areola,
which have a higher concentration of pigment. We take advan-
tage of the low optical attenuation of 1064 nm light to achieve
sufﬁcient optical penetration in breast tissue41.
To provide 2D panoramic in-plane acoustic detection, we
employ a full-ring ultrasonic transducer array with 512 elements.
Four sets of 128-channel data acquisition systems provide
simultaneous one-to-one mapped associations with the 512-
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Fig. 1 Representations of the SBH-PACT system. a Perspective cut-away view of the system with data acquisition components removed. b Perspective view
of the system with patient bed and optical components removed. DAQ data acquisition system, Pre-amp pre-ampliﬁer circuits
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Fig. 2 SBH-PACT of healthy breasts. a Vasculature in the right breast of a 27-year-old healthy female volunteer. Images at four depths are shown in
increasing depth order from the nipple to the chest wall (also see Supplementary Movie 2). b The same breast image with color-encoded depths. c A close-
up view of the region outlined by the magenta dashed box in b, with selected thin vessels and their line spread plots. d A selected vessel tree with ﬁve
vessel bifurcations, labeled from B1 to B5. At each bifurcation, the diameter relationships between the parent vessel (Dparent) and daughter vessels
(Ddaughter) are presented on the right. XB is the junction exponent, and RB is deﬁned as RB ¼ D3parent=ðD3daughter a þ D3daughter bÞ. e Heartbeat-encoded arterial
network mapping of a breast cross-sectional image (red= artery, blue= vein). f Amplitude ﬂuctuation in the time domain of the two pixels highlighted by
yellow and green dots in e. The pixel value in the artery shows changes associated with arterial pulse propagation (also see Supplementary Movie 3). g
Fourier domain of the pixel value ﬂuctuations in f. The oscillation of the arterial pixel value shows the heartbeat frequency at ~1.2 Hz
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element transducer array (Fig. 1b and Supplementary Fig. 1).
Therefore, we acquire photoacoustic signals from a cross section
within 100 µs without multiplexing after each laser pulse
excitation (Methods). The ultrasonic transducer elements have
a central frequency of 2.25 MHz and a one-way bandwidth of
more than 95% (Supplementary Fig. 3), providing an experimen-
tally quantiﬁed in-plane resolution of 255 µm (Supplementary
Fig. 4). The height of each transducer element yields a moderate
divergence angle in the elevational direction (~9.0˚ full width at
half maximum (FWHM)), yielding a ﬂared diffraction pattern
(Supplementary Fig. 5). This pattern enables both 2D imaging of
a breast cross section per laser pulse and 3D imaging of the whole
breast by scanning elevationally (Methods). Our 3D back-
projection algorithm can reconstruct a volumetric image with
an elevational resolution of 5.6 mm, which is ~3 times ﬁner than
that given by the 2D reconstruction algorithm (Supplementary
Fig. 5 and Supplementary Movie 1).
Before imaging breast cancer patients, the performance of
SBH-PACT was assessed by imaging a 27-year-old healthy female
volunteer. By scanning the transducer array elevationally through
her right breast, within one breath hold (~15 s), we revealed the
angiographic anatomy from the nipple to the chest wall (Fig. 2a
and Supplementary Movie 2). The color-encoded depth-resolved
image clearly revealed the detailed angiographic structures of the
entire breast (Fig. 2b), visualizing the vasculature down to an
apparent vascular diameter of 258 µm (Fig. 2c). To accurately
measure the vascular diameters, we identiﬁed vessel boundaries in
different slices through a correlation-based template matching
method42 (Supplementary Fig. 6 and Methods). By doing this, we
further investigated the relationship between parent and daughter
vessels at vascular bifurcations, which is expressed by the junction
exponent (XB)43. We selected a vessel tree in the breast and
marked ﬁve branch levels with distinct colors (Fig. 2d). At ﬁve
vascular bifurcations (B1–B5), we calculated the junction
exponents as well as the ratios between the cube of the diameter
of the parent vessel and the sum of the cubes of the diameters of
the daughter vessels (Fig. 2d). For the eight subjects (one healthy
volunteer and seven breast cancer patients), we picked ﬁve
vascular bifurcations in each of their breasts and quantiﬁed the
average junction exponent (Supplementary Fig. 7), which has a
mean value of 2.63 ± 0.34. The junction exponents generally
decrease with increasing age44, 45.
During a breath hold within 10 s, we imaged a cross section of
the contralateral healthy breast in one of the breast cancer
patients. Working in 2D mode at 10 Hz frame rate, SBH-PACT
continuously monitored arterial pulsatile deformation inside the
breast (Supplementary Movie 3) by ﬁxing the transducer array at a
speciﬁc elevational position46. PA signals were analyzed pixel-wise
in the frequency domain to identify arteries and veins according to
the heartbeat frequency (see Methods) (Fig. 2e). For illustration,
we selected a pixel from one artery and one vein (highlighted by
round dots 1 and 2 respectively in Fig. 2e) and plotted their pixel
value ﬂuctuation (Fig. 2f). The periodic oscillation of the pixel
values in the artery indicates that the changes were the result of
pulse waves propagating through the arterial network. The
oscillation frequency further reveals the subject’s heart rate of
~1.2 Hz (Fig. 2g). Considering that arterial blood has a relatively
narrow range of oxygen saturation (sO2)47, average PA signals
from arteries can potentially be used to calibrate the local optical
ﬂuence (mJ cm−2) deep in the breast, and thus enable accurate
quantiﬁcation of functional parameters (e.g., blood sO2) with an
additional laser wavelength (e.g., 750 nm)48, 49.
SBH-PACT of breast cancer anatomy, segmentation, and
elastography. The improved noise-equivalent sensitivity
(Supplementary Fig. 8) enabled SBH-PACT to detect breast
tumors with ﬁne details, making this imaging modality poten-
tially useful for multiple applications in breast clinical care. We
imaged seven breast cancer patients (Fig. 3), with breast sizes
ranging from B cup to DD cup (over 99% of the U.S. population
has breast sizes of DD cup or smaller50) and skin pigmentations
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ranging from light to dark (Methods). Angiogenesis, which plays
a central role in breast cancer development, invasion, and
metastasis, is the essential hallmark by which SBH-PACT dif-
ferentiates lesions from normal breast tissue23–25. Well correlated
with the tumor locations shown in mammograms and reported
by ultrasound-guided biopsy (Fig. 3a and Methods), SBH-PACT
showed eight of the nine tumors by observing higher blood vessel
densities associated with tumors in the depth-encoded images
(Fig. 3b and Supplementary Fig. 9). We further selected tumor-
containing slices perpendicular to the chest wall (marked by white
dashed lines in Fig. 3b). In these sagittal (side-view) images, the
same tumors, where higher PA amplitude is shown, can be seen at
corresponding locations (Fig. 3c). In the X-ray mammograms of
Patient 1 (P1) and Patient 6 (P6), the lesions in the dense breasts
are barely distinguishable. In comparison, SBH-PACT clearly
revealed the tumors not readily seen in mammograms, not
withstanding the high radiographical density of the breast.
To assist in translation of the technology to a clinical setting,
we developed a tumor segmentation algorithm to distinguish
tumors automatically. Presumably due to angiogenesis, tumors
appear as regions of denser blood vessels in SBH-PACT images
(Fig. 3b). To segment tumors automatically, we extracted the
vessel skeleton and produced a vessel density map of the breast
(local vessel number / local area). The regions with the highest
vessel density highlight the breast tumors (Fig. 3d and Methods).
In addition to direct observation of blood vessel density, SBH-
PACT detected the difference in compliance between tumors and
surrounding normal breast tissue, providing an alternate
concurrent contrast to detect breast cancer. Before performing
elastography on breast cancer patients, we demonstrated this
method on breast-mimicking phantoms (Methods and Supple-
mentary Fig. 10). Working in 2D imaging mode, SBH-PACT
quantiﬁed the relative area changes in a breast cross section when
minor deformations were caused by breathing (Supplementary
Movie 4). Because breast tumors are generally less compliant than
normal breast tissue51, the regions with lower relative area
changes indicated the breast tumor (Fig. 3e). Unlike ultrasonic
elastography, SBH-PACT elastography utilized the contrast of
hemoglobin and formed area-quantiﬁcational grids between
vessels (Methods). From only angiographic anatomy detailed by
SBH-PACT, the only tumor we missed was located in a marginal
region of a D cup breast (P7(L)), where light illumination was
insufﬁcient. However, with the addition of SBH-PACT elasto-
graphy, the missed tumor was identiﬁed. Taking advantage of the
short time requirement for elastographic measurement (~10 s),
SBH-PACT can observe both blood vessel density and tissue
compliance simultaneously within ~30 s. Taken together, these
two measurements can improve the sensitivity of breast cancer
detection.
Statistics. In this pilot study, SBH-PACT identiﬁed eight of the
nine biopsy-veriﬁed tumors by assessing blood vessel density.
Moreover, the initially undetected tumor was subsequently
revealed by elastographic SBH-PACT. Pathology reports showed
two benign tumors (Patient 5, stromal ﬁbrosis or ﬁbroadenoma;
Patient 7, right, ﬁbroadenoma), one ductal carcinoma in situ
(DCIS) with a 3/3 nuclear grade (Patient 2), and six invasive
carcinomas (all other cases).
Angiogenesis serves as a basis for tumor identiﬁcation.
Considering the diversity among the subjects, we deﬁned high
blood vessel densities as values greater than the whole-breast
average plus (a) 1.5, (b) 2.0, or (c) 2.5 times the standard
deviation, respectively. We calculated and compared the ratios of
average vessel density between the high-density region and the
normal-density region in each affected and contralateral breast
(Supplementary Fig. 11). Receiver operating characteristic (ROC)
curves (Fig. 4a) were plotted by varying the threshold of the ratios
from 1 to 6. Based on the data from the ﬁnite set of subjects,
option (b) yielded the largest area (0.90) under the ROC curve. A
threshold within (2.26, 2.58) produced a sensitivity (true positive
rate) of 88% and a speciﬁcity (true negative rate) of 80%. We
further performed training and testing studies by obtaining a
threshold based on randomly picked six breasts (training set) and
then applying the threshold to the remaining seven breasts
(testing set). We repeated this procedure ten times and calculated
the average sensitivity and speciﬁcity (Supplementary Table 1).
We then demarcated tumors in each breast and computed the
average vessel densities inside and outside the tumors (Methods).
The average vessel density ratios between the tumors and the
surrounding normal breast tissues were 3.4 ± 0.99 (Fig. 4b). In
addition, the mean of the average vessel density ratios of the six
malignant tumors was 1.4 times higher than that of the two
benign ones (Supplementary Fig. 12).
Since the elastography study began with Patient 4, SBH-PACT
elastography identiﬁed all ﬁve tumors in the subsequent four
patients (Fig. 4c). The average breath-induced area change in
tumors was around 2 times lower than that in normal breast
tissue. As the patient recruitment protocol excluded patients with
a mass smaller than 1 cm in diameter in this pilot study, the
longest dimension of the smallest tumor we detected was
approximately 0.8 cm (Fig. 4d). This tumor was located in the
right breast of Patient 7, who was recruited due to a larger tumor
in her left breast. However, with 255 µm spatial resolution and
reﬁned noise-equivalent sensitivity, SBH-PACT has the potential
to detect smaller breast cancers once angiogenesis sufﬁciently
progressed. Patient 3 had DD cup breasts, and her breast was
compressed against the chest wall to roughly a cylinder. The
tumor in her breast had a depth of ~3.2 cm (elevational distance
from the nipple), which was the deepest among the recruited
patients (Fig. 4d).
Discussion
We have developed an SBH-PACT system that integrates deep
penetration, high spatiotemporal resolution, sensitive breast
cancer detection, and 2D/3D switchable modes. One-to-one
mapped low-noise ampliﬁers and DAQ circuits enabled 2D
Fig. 3 SBH-PACT of cancerous breasts. a X-ray mammograms of the
affected breasts of seven breast cancer patients. LCC left cranial-caudal,
LLM left lateral-medio, LML left mediolateral, LMLO left mediolateral-
oblique, RCC right cranial-caudal, RML right medio-lateral. b Depth-
encoded angiograms of the eight affected breasts acquired by SBH-PACT.
Breast tumors are identiﬁed by white circles. For illustration, we marked the
nipple of the ﬁrst patient (P1) with a magenta circle. P1—48-year-old female
patient with an invasive lobular carcinoma (grade 1/3); P2—70-year-old
female patient with a ductal carcinoma in situ (microinvasion grade 3/3);
P3—35-year-old female patient with two invasive ductal carcinomas (grade
3/3); P4—71-year-old female patient with an invasive ductal carcinoma
(grade 3/3); P5—49-year-old woman with a stromal ﬁbrosis or
ﬁbroadenoma; P6—69-year-old female patient with an invasive ductal
carcinoma (grade 2/3); P7—44-year-old female patient with a
ﬁbroadenoma in the right breast and an invasive ductal carcinoma (grade
2/3) in the left breast. c Maximum amplitude projection (MAP) images of
thick slices in sagittal planes marked by white dashed lines in b. d
Automatic tumor detection on vessel density maps. Tumors are identiﬁed
by green circles. Background images in gray scale are the MAP of vessels
deeper than the nipple. eMaps of the relative area change during breathing
in the regions outlined by blue dashed boxes in the angiographic images in
d. The same tumors are identiﬁed by red circles. The elastographic study
began with Patient 4, and it revealed all imaged tumors, including the
undetected one in d (P7(L))
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imaging using a single laser impulse or 3D imaging of an entire
breast within a single breath hold (~15 s). The high imaging speed
avoided respiration-induced motion artifacts and enabled detec-
tion of breast tumors by detailing tumor associated angiogenesis.
The donut-shaped optical illumination and panoramic acoustic
detection provided a more uniform ﬂuence distribution in deep
tissue and best in-plane coverage of ultrasound reception,
respectively, delivering high image quality. Furthermore, con-
sidering the low cancer detection rate (0.41%)52, even though
modern mammography uses a low dose of ionizing radiation, the
risk-to-beneﬁt ratio (e.g., 8–17% https://www.ncbi.nlm.nih.gov/
pubmed/11388061 for 40–50 year-old women)53, 54 is considered
high. In comparison, SBH-PACT requires neither ionizing
radiation nor an exogenous contrast agent, yielding zero risk.
In SBH-PACT, the laser beam was broadened into a donut
shape with an outer diameter of ~10 cm, depositing light with an
average laser ﬂuence of ~20 mJ cm−2 on the breast surface (only
1/5 of the American National Standards Institutes safety limit)55.
This outer radius covered most breasts and provided satisfactory
SNR in breast images. Merely assessing blood vessel density, we
missed one tumor, which was located in an insufﬁciently illu-
minated marginal region of a D cup breast (P7(L) in Fig. 3a).
Therefore, SBH-PACT can potentially improve sensitivity further
in breast cancer detection if equipped with a more energetic laser,
which will allow us to enlarge the illumination area and increase
the optical ﬂuence.
Our automatic tumor segmentation algorithm made it easier to
recognize tumors by highlighting the suspicious affected region
with the highest vessel density. In addition, the high 2D imaging
speed of SBH-PACT (10 Hz frame rate) enabled us to perform
elastographic measurements and to improve on breast cancer
detection. The capability of SBH-PACT to map arterial
distribution can potentially be useful in diagnosing artery-related
diseases56–58. In addition, the knowledge of vessel diameters and
average PA signals from arteries can be used to calibrate the local
optical ﬂuence48, 49, thus providing accurate spectral sO2 mea-
surement in deep tissue.
By developing this advanced breast imaging modality, we pro-
vided a promising tool for future clinical use including not only
screening, but also diagnostic studies to determine extent of dis-
ease, to assist in surgical treatment planning, and to assess
responses to neoadjuvant chemotherapy. Compared to mammo-
graphy, SBH-PACT utilizes non-ionizing radiation, shows early
promise for sensitivity in radiographically dense breasts, and
imposes less or no pain by only slightly compressing the breast
against the chest wall. Because the average hemoglobin con-
centration in malignant tumors is generally twice that in benign
tumors59–61, SBH-PACT has the potential to distinguish malignant
tumors from benign tumors by quantifying blood vessel densities
in the tumor (Supplementary Fig. 12). Based on the vessel density
in the two benign tumors and the six detected malignant ones in
this study, the threshold of the vessel density ratio between tumors
(either malignant or benign) and healthy tissues should be set
within the range of (2.72, 2.76) to optimally differentiate malignant
tumors from benign ones; however, more patients need to be
imaged to achieve statistical signiﬁcance. Using hemoglobin as the
contrast, SBH-PACT can potentially monitor breast cancer’s
response to neoadjuvant chemotherapy by acquiring information
similar to that of contrast-enhanced MRI, yet with ﬁner spatial
resolution, higher imaging speed, and only endogenous contrast.
Methods
System construction. The SBH-PACT system mainly comprises of an illumina-
tion laser, an ultrasonic transducer array, signal ampliﬁcation/acquisition modules,
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a linear scanning stage, and a patient bed (Fig. 1). The 1064-nm laser beam (PRO-
350-10, Quanta-Ray, 10-Hz pulse repetition rate, 8–12-ns pulse width) was ﬁrst
passed through a lab-polished axicon lens (25 mm diameter, 160° apex angle), then
expanded by an engineered diffuser (EDC-10-A-2 s, RPC Photonics) to form a
donut-shaped light beam. The laser ﬂuence (20 mJ cm−2) was within the American
National Standards Institutes (ANSI) safety limit for laser exposure (100 mJ cm−2
at 1064 nm at a 10-Hz pulse repetition rate)55. To synchronize the SBH-PACT
system, the laser’s external trigger was used to trigger both the data acquisition
systems and the linear scanner.
To achieve 2D panoramic acoustic detection, we employed a 512-element full-
ring ultrasonic transducer array (Imasonic, Inc.; 220 mm ring diameter; 2.25MHz
central frequency; more than 95% one-way bandwidth; Supplementary Fig. 3).
Each element had a ﬂat-rectangular aperture (5 mm element elevation size; 1.35
mm pitch; 0.7 mm inter-element spacing). The ultrasonic transducer array housing
was mounted on a stainless steel rod (25 mm diameter) and enclosed in an acrylic
water tank. A linear stage (THK America, Inc., KR4610D) was ﬁxed beneath the
water tank and moved the transducer array elevationally via the stainless steel rod.
Four sets of lab-made 128-channel preampliﬁers (26 dB gain) were placed around
the water tank, connected to the ultrasonic array housing via signal cable bundles.
Each set of preampliﬁers was further connected to a 128-channel data acquisition
system (SonixDAQ, Ultrasonix Medical ULC; 40 MHz sampling rate; 12 bit
dynamic range) with programmable ampliﬁcation up to 51 dB. The digitized radio
frequency data were ﬁrst stored in an onboard buffer, and then transferred to a
computer through a universal serial bus 2.0 (Supplementary Fig. 1). The data
acquisition systems were set to record PA signals within 100 µs after each laser
pulse excitation.
The patient is positioned prone with one breast dependent and placed into a
large aperture in the bed. An agar pillow afﬁxed on top of an acrylic tube lightly
pressed the breast against the chest wall. The bed top was covered by cushioning
memory foam. The water tank was fully ﬁlled with water preheated to a
temperature of 35 °C. Both the patient bed and the SBH-PACT system were
supported by T-slotted aluminum frames.
Half-time PA reconstruction in 2D and 3D modes. We used the half-time
universal back-projection (UBP) algorithm62 to reconstruct all images in this work.
In 2D imaging mode, the time-domain PA signals generated by each laser pulse
were back-projected to a 2D imaging plane. Determined by the acoustic divergence
angle (~9.0˚) at FWHM in the elevational direction (Supplementary Fig. 5), the
elevational resolution at the center was ~16.1 mm.
Alternatively, when working in 3D mode, the ultrasonic transducer array
scanned the entire breast from the chest wall to the nipple. The time-domain PA
signals acquired at all elevational scanning steps were then back-projected
simultaneously into the 3D space. To accommodate the acoustic divergence angle
in the elevational direction, 3D-UBP added a weight to the back-projected PA
signals at different elevational divergence angles (Supplementary Fig. 5). To
accurately reconstruct objects in the Fraunhofer zone, we back-projected PA
signals from virtual transducers located at the transition points between the Fresnel
and Fraunhofer zones63. Sharing the same in-plane resolution as the 2D mode, 3D-
UBP provided an improved elevational resolution of 5.6 mm.
The full-ring transducer array with 512 elements could spatially well sample
objects— according to the spatial Nyquist criterion— within a ﬁeld of view (FOV)
of ~39 mm in diameter39. To eliminate aliasing caused by under-sampling in
regions outside of this FOV, we low-pass ﬁltered PA signals with cut-off
frequencies determined by the distance to the center of the ring array.
Each volumetric image was ﬁrst reconstructed with a voxel size of 1 mm in the
elevational direction and 0.1 × 0.1 mm2 on the horizontal plane. We then batch-
processed all the reconstructed images to improve contrast (batch processing
before vesselness ﬁltering in Supplementary Fig. 9). In each horizontal slice, we
applied Hessian-based Frangi vesselness ﬁltration39 to enhance the contrast of
blood vessels with diameters ranging from 3 to 12 pixels. In each ﬁltered slice,
adaptive thresholding was used to segment blood vessels42, followed by
morphology ﬁltration for single-pixel elimination. In the elevational direction of
each ﬁltered volumetric image, we selected voxels with the largest PA amplitudes
and then projected their depths to form a 2D image. We applied median ﬁltration
with a window size of 3 × 3 pixels to the depth image. Another median ﬁltration
with a window size of 6 × 6 pixels was further applied inside the segmented vessels
to the segmented vessels’ depths. Different RGB (red, green, blue) color values were
assigned to discrete depths (vertical color bar in Fig. 2b). Finally, the 2D depth-
resolved color-encoded image was multiplied by the MAP image pixel by pixel to
represent the maximum amplitudes (horizontal color bar in Fig. 2b). To further
reduce noise and improve image quality, we also tuned the above parameters in 2D
slices at different depths (custom processing in Supplementary Fig. 9). As shown in
Supplementary Fig. 9, the structures in all three sets of images match well with each
other, showing the ﬁdelity of the vesselness ﬁltering and custom processing.
Vascular diameter measurement. Vascular diameters were accurately measured
by identifying vessel boundaries through a correlation-based template matching
method42. The templates were generated through simulation (Supplementary
Fig. 6). The impulse responses of all ultrasonic transducers were used to simulate
the images of vessels with different sizes (0.5–2.0 mm) and orientations. The
diameters of vessels chosen from the SBH-PACT breast images were quantiﬁed by
matching the reconstructed vessel images with the generated templates.
Arterial vessel mapping. Working in 2D imaging mode, SBH-PACT was able to
monitor blood ﬂow-mediated arterial ﬂuctuation (Supplementary Movie 3). After
removing displacement through rigid transformation, we analyzed the pixel value
ﬂuctuation during a patient’s breath hold (~10 s). We found that arteries ﬂuctuated
much more than veins at the frequency of the heartbeat. The ﬂuctuation of the
pixel values in the artery indicated the changes associated with arterial pulse
propagation (Fig. 2g).
To separate ﬂuctuations caused only by heart beats, frames with strong motion
caused by body movement were ﬁrst removed. The entire imaging ﬁeld was then
divided into 16 slightly overlapping subdomains. In each subdomain, we chose the
ﬁrst frame as the reference frame; other frames were registered to it through rigid
transformation, optimizing the frame–frame correlation. In each subdomain, a
Gaussian ﬁlter with a radius of 0.2 mm was applied to all registered frames to
reduce high spatial-frequency noise. We then applied Fourier transformation to
each pixel’s value through all the frames. The ﬂuctuations in pixel values induced
by arterial pulse propagation were quantiﬁed within the frequency range (1.0–1.6
Hz) of heartbeat cycles64.
Tumor segmentation. SBH-PACT showed breast masses by revealing a greater
density of blood vessels, presumably due to angiogenesis, in tumor regions. To
segment tumors automatically, we extracted the vessel skeleton and produced a
vessel density (number of vessels / area) map of the breast. The regions with the
highest vessel density highlighted the breast mass of interest (Fig. 3d).
The dense vessels in the nipple would affect the automatic tumor segmentation.
Therefore, the shallowest slices containing the nipple were ﬁrst removed. The
remaining slices were used to generate the MAP image. A vessel mask was
generated from the MAP by Hessian ﬁltering and threshold-based segmentation.
Based on the mask, vessel centerlines were extracted by removing boundary pixels.
The vessel centerlines were broken into independent vessels at junction points. To
reduce noise further, we removed independent vessels with lengths less than 3
pixels (255 µm spatial resolution divided by 100 µm pixel size is approximately 3).
A 2 mm × 2mm window was then used to scan the entire image. At each scanning
location, the number of vessels (independent segments) inside the window was
counted and assigned to the center pixel in the window. The vessel density was
quantiﬁed as the number of vessels divided by the window area. To compute the
average vessel density of the whole breast, we included pixels inside a 10 cm-
diameter circle around the image center.
To demarcate breast tumors from MAP images, we ﬁrst identiﬁed suspicious
regions where blood vessel densities were higher than a threshold, which was set to
each whole-breast’s average plus 2.0 times the standard deviation. Among the eight
affected breasts, the smallest suspicious region had a diameter of 1 mm. We then
counted the numbers of pixels in each contiguous region and rejected the regions
with pixel counts fewer than 1855 (18.55 mm2) to eliminate false positive cases
(Supplementary Fig. 13). The remaining contiguous regions were labeled as tumors
and the smallest one had a longest dimension of 8 mm (Fig. 4d). In comparison,
contrast-enhanced MRI on a 1.5 Tesla scanner can detect breast tumors as small as
4 mm, which is similar to the smallest size of tumors detectable by X-ray
mammography65, 66.
Elastographic study. SBH-PACT’s high imaging speed enabled differentiation in
compliance between tumors and surrounding normal breast tissues, providing
another contrast for detecting breast cancer. We ﬁrst performed
SBH-PACT elastographic measurements on a breast phantom. The phantom
comprised a ball with 7% agar (mimicking breast tumor) embedded in a base of 2%
agar (mimicking normal breast tissue)67. Chopped human hair was uniformly
distributed in the phantom to mimic small blood vessels. Working in 2D imaging
mode, SBH-PACT quantiﬁed the relative area changes in a cross section when
minor deformations were induced by periodic compressions (~0.25 Hz) on top of
the phantom. Due to the low elevational sectioning power of 2D imaging, objects in
2D frames were mainly inﬂuenced by coronal dilation instead of elevational dis-
placement. Accordingly, SBH-PACT elastography clearly revealed the agar ball
with correct size and location (Supplementary Fig. 10). No obvious differences were
observed in the concentration of the hair ﬁber between the balls and the phantom
base.
To assess deformations over time, the ﬁrst frame was taken as a reference. Other
frames were registered to the ﬁrst frame through a non-rigid demon algorithm68 in
Matlab. For each pixel of registered frames, the standard deviation (STD) of the
value variations was calculated. Pixels with relatively small STDs were stably
registered and were used for deformation quantiﬁcation. The entire image was then
segmented into 2 mm × 2mm squares. One stably registered pixel was chosen from
each square, and triangular grids were further generated from these registered
pixels. The triangular grids were mapped back to the original unregistered frames,
and their areas were calculated. For each grid, Fourier transformation was applied
to quantify the area variation at the frequency of periodic compression, and
amplitudes were assigned to the pixels inside this triangle to generate the
deformation map. To further reduce noise, 100 deformation maps were generated
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with randomly registered pixels in the squares. The ﬁnal image is the average of the
100 deformation maps.
To conduct SHB-PACT elastography of the breast, patients were asked to
breathe normally. The chest wall pushed the breast against the agar pillow,
elevationally generating a deformation of the breast in the coronal plane. We used
the same method to quantify the change of area between blood vessels in the breast.
Tumors, being stiffer, could be identiﬁed in areas with less deformation than
normal breast tissue.
Patient recruitment and human experiment protocols. All the human experi-
ments followed protocols approved by the Institutional Review Board (IRB) and
Protocol Review and Monitoring Committee (PRMC) of Washington University in
St. Louis. We enrolled one healthy volunteer and seven female patients with
consent documents signed. All recruited patients met the following inclusion cri-
teria: (1) Patients were newly diagnosed with breast tumors highly suspicious for
malignancy, larger than 1 cm in diameter, and were eligible for percutaneous
biopsy; (2) Patients were females >18 years of age; (3) Patients were able to
understand and willing to sign a written informed consent document. The exclu-
sion criteria included (1) patients whose weight exceeded 300 lbs (the weight limit
of the steps for mounting the bed); (2) patients who were pregnant; (3) patients
with uncontrolled intercurrent illness including, but not limited to, ongoing or
active infection of the breast and/or axilla, symptomatic congestive heart failure,
unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations
that would limit compliance with study requirements.
Photoacoustic imaging was performed after a standard of care (SOC) work-up,
but in advance of percutaneous biopsy. This order of events was designed to
minimize confounding imaging ﬁndings related to biopsy-induced hemorrhage.
Patients underwent only one PACT imaging study, which took less than 10 min.
We imaged both the contralateral and affected breasts. For the abnormal breast, we
analyzed the tumor size, tumor depth, blood vessel density, and signal amplitude in
the breast images. Our analysis of tumor size/depth was further compared with the
standard imaging results (mammography and ultrasonography). To identify the
tumor types and grades, histopathology results from the SOC biopsy were used as
the ground truth for interpretation of the results.
Standard of care work-up, percutaneous biopsy, and pathologic diagnosis.
Patients were imaged at the Joanne Knight Breast Health Center at Siteman Cancer
Center in partnership with Washington University School of Medicine (WUSM),
Mallinckrodt Institute of Radiology. All standard of care imaging was performed by
subspecialist breast imaging physicians who are faculty of WUSM. Using estab-
lished clinical protocols, abnormalities were identiﬁed either through routine
screening mammography, or diagnostic evaluation in symptomatic patients. Pre-
biopsy work up included combinations of digital mammography, digital breast
tomosynthesis, and ultrasound. Formal BI-RADS (breast imaging, reporting and
data system) assessments were assigned in all cases, with appropriate recommen-
dation for biopsy. Eligible patients were approached and informed consent
obtained in advance of the biopsy. Image-guided percutaneous biopsy was obtained
using real-time ultrasound guidance and a 12-guage or 14-guage spring-loaded
biopsy needle (chosen at the discretion of the performing physician.). Core spe-
cimens were submitted in formalin to the pathology department for histologic
analysis as per normal routine at the institution. All cases were reviewed following
receipt of the ﬁnal pathology report to determine radiologic-pathologic correlation.
Some patients underwent contrast enhanced breast MRI following conﬁrmation of
malignancy.
Data availability. All data are available within the Article and Supplementary Files,
or available from the authors upon request.
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